Augtyro 40 mg/1 (Repotrectinib CAPSULE) 40 mg/1

Augtyro 40 mg capsules contain repotrectinib, a medication used for targeted therapy. Learn about its uses, effects, and precautions here.

Strength

40 mg/1

Pack Size

60 CAPSULE in 1 BOTTLE (0003-4040-60)

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Augtyro 40 mg capsules are primarily used for targeted therapy in certain types of cancer. Repotrectinib is designed to target specific proteins involved in cancer cell growth. This medication may be prescribed for conditions where these proteins are overactive, contributing to the proliferation of cancer cells. Always consult a healthcare provider to determine if Augtyro is suitable for your specific condition.

Side Effects

Common effects of Augtyro 40 mg capsules may include fatigue, nausea, and dizziness. Some individuals might experience changes in taste or vision. These effects can vary widely among users, and not everyone will experience them. If you notice any severe or persistent side effects, it is important to seek medical advice.

Precautions & Warnings

Augtyro 40 mg capsules should be handled with care. Store them at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Always follow the storage instructions provided by your healthcare provider to maintain the effectiveness of the medication.

Avoid Interactions

Augtyro 40 mg capsules may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances may also interact with repotrectinib, so it is advisable to discuss your lifestyle habits with your healthcare provider.

Frequently Asked Questions

Augtyro 40 mg capsules are used for targeted therapy in certain types of cancer, focusing on proteins involved in cancer cell growth.

Augtyro 40 mg capsules are taken orally, typically as prescribed by a healthcare provider. Follow the instructions provided with the medication.

Common side effects may include fatigue, nausea, dizziness, changes in taste, and vision changes. Severe or persistent effects should be discussed with a healthcare provider.

It is advisable to discuss alcohol consumption with your healthcare provider, as alcohol may interact with repotrectinib.

Store Augtyro 40 mg capsules at room temperature away from moisture and heat, and keep them out of reach of children and pets.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.